From: Significance of the neutrophil-to-lymphocyte ratio in predicting the response to neoadjuvant chemotherapy in extremity osteosarcoma: a multicentre retrospective study
Variable
OR
95%CI
P value
Tumor size≤195.37 vs >195.37
1.43
0.29-6.88
0.65
Enneking stage Ivs II/III
0.98
0.31-3.21
LNLR vs HNLR
2.82
1.36-5.17
0.02
LPLR vs HPLR
0.73
0.10-5.41
0.76